FDA's Janet Woodcock, October 2019 testimony: only 28 percent of the factories making drug ingredients for the U.S. market were in the U.S., and the FDA cannot say precisely how much China produces.
As of August 2019, only 28 percent of the manufacturing facilities making APIs to supply the U.S. market were in our country.
2
FDA's Janet Woodcock, October 2019 testimony: only 28 percent of the factories making drug ingredients for the U.S. market were in the U.S., and the FDA cannot say precisely how much China produces.